NO932053D0 - Nye farmasoeytiske preparater inneholdende en farmakologisk aktiv ioniserbar substans samt fremgangsmaate for fremstilling derav - Google Patents

Nye farmasoeytiske preparater inneholdende en farmakologisk aktiv ioniserbar substans samt fremgangsmaate for fremstilling derav

Info

Publication number
NO932053D0
NO932053D0 NO1993932053A NO932053A NO932053D0 NO 932053 D0 NO932053 D0 NO 932053D0 NO 1993932053 A NO1993932053 A NO 1993932053A NO 932053 A NO932053 A NO 932053A NO 932053 D0 NO932053 D0 NO 932053D0
Authority
NO
Norway
Prior art keywords
procedures
preparing
pharmaceutical preparations
preparations containing
new pharmaceutical
Prior art date
Application number
NO1993932053A
Other languages
English (en)
Other versions
NO305536B1 (no
NO932053L (no
Inventor
Bengt Lindstedt
Per Johan Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO932053D0 publication Critical patent/NO932053D0/no
Publication of NO932053L publication Critical patent/NO932053L/no
Publication of NO305536B1 publication Critical patent/NO305536B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO932053A 1990-12-07 1993-06-04 FremgangsmÕte for fremstilling av et komprimert oralt preparat NO305536B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations
PCT/SE1991/000814 WO1992010171A1 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof

Publications (3)

Publication Number Publication Date
NO932053D0 true NO932053D0 (no) 1993-06-04
NO932053L NO932053L (no) 1993-07-20
NO305536B1 NO305536B1 (no) 1999-06-21

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932053A NO305536B1 (no) 1990-12-07 1993-06-04 FremgangsmÕte for fremstilling av et komprimert oralt preparat

Country Status (17)

Country Link
US (2) US5707656A (no)
EP (1) EP0560816B1 (no)
JP (1) JP3276956B2 (no)
AT (1) ATE444737T1 (no)
AU (1) AU656346B2 (no)
CA (1) CA2097176C (no)
DE (1) DE69133623D1 (no)
EE (1) EE03105B1 (no)
FI (1) FI932553A (no)
HU (1) HU218661B (no)
IE (1) IE914136A1 (no)
IS (1) IS1749B (no)
NO (1) NO305536B1 (no)
PT (1) PT99720B (no)
SE (1) SE9003903D0 (no)
WO (1) WO1992010171A1 (no)
YU (1) YU186791A (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69738966D1 (de) * 1996-12-20 2008-10-16 Mcneil Ppc Inc Durch ionenaustauscherharze verabreichte hustenmittel
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
WO2001008661A2 (en) * 1999-07-29 2001-02-08 Roxane Laboratories, Inc. Opioid sustained-released formulation
CN1551770A (zh) * 2001-07-06 2004-12-01 ������ҩ�����޹�˾ 羟吗啡酮控释制剂
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
WO2007010900A1 (ja) * 2005-07-15 2007-01-25 Transcu Ltd. 貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
WO2007026671A1 (ja) * 2005-08-29 2007-03-08 Transcu Ltd. センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
NZ566628A (en) * 2005-09-16 2010-02-26 Tti Ellebeau Inc Catheter type iontophoresis apparatus using alternating layers of electrolytes and ion exchange membranes
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
CN101277737A (zh) * 2005-09-30 2008-10-01 Tti优而美株式会社 将多种活性剂输送至生物界面的离子电渗装置
US20090187134A1 (en) * 2005-09-30 2009-07-23 Hidero Akiyama Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
EP2123259A1 (en) * 2007-01-16 2009-11-25 Hokkaido University Liposome preparation for iontophoresis having antioxidant component encapsulated therein
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
CA2736495A1 (en) * 2008-09-10 2010-03-18 Gregory A. Smith Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
CA2757337A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
NO305536B1 (no) 1999-06-21
DE69133623D1 (de) 2009-11-19
HU9301671D0 (en) 1993-09-28
FI932553A0 (fi) 1993-06-04
PT99720B (pt) 2002-04-29
US5709882A (en) 1998-01-20
HU218661B (hu) 2000-10-28
WO1992010171A1 (en) 1992-06-25
EE03105B1 (et) 1998-08-17
EP0560816A1 (en) 1993-09-22
YU186791A (sh) 1994-04-05
IS3787A7 (is) 1992-06-08
IS1749B (is) 2000-07-11
AU656346B2 (en) 1995-02-02
PT99720A (pt) 1992-10-30
CA2097176A1 (en) 1992-06-08
US5707656A (en) 1998-01-13
JPH06503311A (ja) 1994-04-14
CA2097176C (en) 2002-03-26
NO932053L (no) 1993-07-20
ATE444737T1 (de) 2009-10-15
HUT64213A (en) 1993-12-28
JP3276956B2 (ja) 2002-04-22
SE9003903D0 (sv) 1990-12-07
FI932553A (fi) 1993-06-04
EP0560816B1 (en) 2009-10-07
IE914136A1 (en) 1992-06-17
AU8930591A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
NO932053D0 (no) Nye farmasoeytiske preparater inneholdende en farmakologisk aktiv ioniserbar substans samt fremgangsmaate for fremstilling derav
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
GEP20063773B (en) Steroid Sulphatase Inhibitors
MY105279A (en) Transdermal therapeutic system comprising tulobuterol as active substance.
ES2177609T3 (es) Pluma de administracion de medicacion con una escala para fijacion de la dosis.
FI901556A0 (fi) Foerfarande foer framstaellning av ett transdermalt terapeutiskt system med foerstorad stroemning av det verkande aemnet.
ATE208632T1 (de) Verabreichungssystem für phospholipide
EP0177893A3 (en) Sustained release dosage form based on highly plasticized cellulose ether gels
NO304266B1 (no) Nye estere av bi- og tricykliske aminoalkoholer, i legemidler inneholdende slike, samt deres anvendelse til fremstilling av legemidler
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
DK581685A (da) Transderimalt system for timolol-indgift
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
ATE42202T1 (de) Therapeutische zubereitung mit ammoniumnitrat als wirkstoff.
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
SE8902624D0 (sv) New pharmaceutical preparations
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
GR3002665T3 (en) Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
UA12334A (uk) Трансдермальна терапевтична система та спосіб її одержання
IT212968Z2 (it) Monouso monodose per l' iniezione perfezionamenti ad una cartuccia di una sostanza liquida in una parte del corpo umano.
RU95120122A (ru) Способ лечения хронического простатита
HRP930586A2 (en) Process for the production of transdermal therapeutic em with norpseudoeffedrine as an active substance
ATE68975T1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
IT8940141A0 (it) Filo medicato per somministrare localmente medicamenti

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003